Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K/A
2021 FY
Annual report (amended)
29 Apr 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
Completion of Acquisition or Disposition of Assets
16 Feb 24
8-K
Regulation FD Disclosure
11 Jan 24
8-K
Glucotrack Announces Early Accuracy Data for Its Implantable Continuous Glucose Monitor
2 Jan 24
8-K
GLUCOTRACK ANNOUNCES 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
30 Nov 23
8-K
Glucotrack Announces Preclinical Testing with Implantable Continuous Glucose Monitor
13 Oct 23
8-K
Departure of Directors or Certain Officers
12 Oct 23
8-K
Departure of Directors or Certain Officers
31 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 May 23
8-K
Entry into a Material Definitive Agreement
17 Apr 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
17 Apr 23
424B5
Prospectus supplement for primary offering
13 Apr 23
8-A12B
Registration of securities on exchange
8 Dec 21
S-3
Shelf registration
20 Sep 21
D
$15M in equity, sold $15M, 1 investor
28 Feb 20
424B3
Prospectus supplement
20 Aug 18
424B3
Prospectus supplement
2 Jul 18
POS AM
Prospectus update (post-effective amendment)
7 Jun 18
S-1/A
IPO registration (amended)
21 Dec 17
D
$10M in equity / options / securities to be acquired, sold $425K, 6 investors
11 Dec 17
Proxies
DEF 14A
Definitive proxy
1 Apr 24
PRE 14A
Preliminary proxy
22 Mar 24
DEF 14A
Definitive proxy
2 Mar 23
DEF 14A
Definitive proxy
26 Feb 20
PRE 14A
Preliminary proxy
11 Feb 20
DEF 14A
Definitive proxy
23 Nov 18
PRE 14A
Preliminary proxy
13 Nov 18
DEFA14A
Additional proxy soliciting materials
6 Mar 18
DEFR14A
Revised proxy
2 Mar 18
DEF 14A
Definitive proxy
1 Mar 18
Other
CERT
Certification of approval for exchange listing
9 Dec 21
EFFECT
Notice of effectiveness
28 Sep 21
CORRESP
Correspondence with SEC
23 Sep 21
UPLOAD
Letter from SEC
23 Sep 21
EFFECT
Notice of effectiveness
2 Jul 18
EFFECT
Notice of effectiveness
26 Dec 17
CORRESP
Correspondence with SEC
21 Dec 17
CORRESP
Correspondence with SEC
8 Dec 17
UPLOAD
Letter from SEC
29 Nov 17
EFFECT
Notice of effectiveness
15 Jul 16
Ownership
SC 13G
SABBY MANAGEMENT, LLC
3 Jan 24
3
James S Cardwell
18 Oct 23
3
Erin Catherine Carter
11 Sep 23
3
Allen Danzig
10 Aug 22
SC 13D
Beneficial ownership report
25 Feb 20
3
Shimon D Rapps
14 Aug 19
3
DREW SYCOFF
19 Jul 19
3
david podwalski
28 Jun 17
4
david podwalski
28 Jun 17
4/A
REVAN SCHWARTZ
9 Jun 17